Impact of COVID-19 on Acute Myocardial Infarction Care

Guddeti, Raviteja; Yıldız, Mehmet; Nayak, Keshav R.; Alraies, M. Chadi; Davidson, Laura; Henry, Timothy D.; García, Santiago

doi:10.1016/j.hfc.2022.08.004

Cited by 5 publications

(2 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From these, those with AMI (with or without prior CVS disease) were reported to have higher mortality rates, arrhythmias, acute respiratory distress, acute kidney injury, and electrolyte alteration [1]. Such patients were the unfortunate ones, due to major drawbacks in AMI-COVID-19 patient care: late presentation to the emergency unit (due to possible fear of contamination), prolonged door to balloon time, worsening outcomes, and decrease in ST-elevated AMI activations [20][21][22].…”

Section: Ami-covid-19 Patient Characteristicsmentioning

confidence: 99%

Acute Myocardial Infarction in COVID-19 Patients—A Review of Literature Data and Two-Case Report Series

Nechita,

Niculet,

Baroiu

et al. 2024

JCM

View full text Add to dashboard Cite

Background/Objectives: The newly emergent COVID-19 pandemic involved primarily the respiratory system and had also major cardiovascular system (CVS) implications, revealed by acute myocardial infarction (AMI), arrhythmias, myocardial injury, and thromboembolism. CVS involvement is done through main mechanisms—direct and indirect heart muscle injury, with high mortality rates, worse short-term outcomes, and severe complications. AMI is the echo of myocardial injury (revealed by increases in CK, CK-MB, and troponin serum markers—which are taken into consideration as possible COVID-19 risk stratification markers). When studying myocardial injury, physicians can make use of imaging studies, such as cardiac MRI, transthoracic (or transesophageal) echocardiography, coronary angiography, cardiac computed tomography, and nuclear imaging (which have been used in cases where angiography was not possible), or even endomyocardial biopsy (which is not always available or feasible). Two-case-series presentations: We present the cases of two COVID-19 positive male patients who were admitted into the Clinical Department of Cardiology in “Sfântul Apostol Andrei” Emergency Clinical Hospital of Galați (Romania), who presented with acute cardiac distress symptoms and have been diagnosed with ST elevation AMI. The patients were 82 and 57 years old, respectively, with moderate and severe forms of COVID-19, and were diagnosed with anteroseptal left ventricular AMI and extensive anterior transmural left ventricular AMI (with ventricular fibrillation at presentation), respectively. The first patient was a non-smoker and non-drinker with no associated comorbidities, and was later discharged, while the second one died due to AMI complications. Conclusions: From this two-case series, we extract the following: old age alone is not a significant risk factor for adverse outcomes in COVID-19-related CVS events, and that the cumulative effects of several patient-associated risk factors (be it either for severe forms of COVID-19 and/or acute cardiac injury) will most probably lead to poor patient prognosis (death). At the same time, serum cardiac enzymes, dynamic ECG changes, along with newly developed echocardiographic modifications are indicators for poor prognosis in acute cardiac injury in COVID-19 patients with acute myocardial injury, regardless of the presence of right ventricular dysfunction (due to pulmonary hypertension).

show abstract

Section: Ami-covid-19 Patient Characteristicsmentioning

confidence: 99%

Acute Myocardial Infarction in COVID-19 Patients—A Review of Literature Data and Two-Case Report Series

Nechita,

Niculet,

Baroiu

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“…Research indicates that deficiencies in the healthcare system, coupled with the challenges of accessing healthcare during a pandemic, have had a substantial impact on admissions and care for ST-elevation myocardial infarction (STEMI) [ 3 ]. One notable consequence of the COVID-19 pandemic was a substantial decrease of around 40% in cases of STEMI compared to the pre-pandemic period [ 4 ]. STEMI, characterized by myocardial ischemia, EKG changes, and chest pain, results from coronary artery occlusion, commonly caused by plaque-related issues [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes

Choi,

Maity,

Qureshi

et al. 2024

Cureus

View full text Add to dashboard Cite

The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.

show abstract

Long-term results of ST-segment elevation myocardial infarction management using recombinant prourokinase or primary percutaneous coronary intervention

Milenkina,

Staroverov

2023

Kardio. vestn.

View full text Add to dashboard Cite

Impact of COVID-19 on Acute Myocardial Infarction Care

Cited by 5 publications

References 47 publications

Acute Myocardial Infarction in COVID-19 Patients—A Review of Literature Data and Two-Case Report Series

Acute Myocardial Infarction in COVID-19 Patients—A Review of Literature Data and Two-Case Report Series

Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes

Long-term results of ST-segment elevation myocardial infarction management using recombinant prourokinase or primary percutaneous coronary intervention

Contact Info

Product

Resources

About